A carregar...

AB028. Current status of pharmacotherapy for erectile dysfunction

The advent of phosphodiesterase type 5 (PDE5) inhibition as oral therapy has significantly revolutionized both clinical and basic research in the area of erectile dysfunction (ED). Much of this progress is due to a better understanding in the last three decades of the various pathophysiological and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Androl Urol
Autor principal: Adaikan, P Ganesan
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4842658/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2016.s028
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!